SRTS logo

SRTS
Sensus Healthcare Inc

1,168
Mkt Cap
$72.76M
Volume
11,615.00
52W High
$5.92
52W Low
$3.03
PE Ratio
-9.35
SRTS Fundamentals
Price
$4.32
Prev Close
$4.42
Open
$4.44
50D MA
$4.31
Beta
0.97
Avg. Volume
67,907.56
EPS (Annual)
-$0.4728
P/B
1.51
Rev/Employee
$458,033.33
$43.37
Loading...
Loading...
News
all
press releases
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...
MarketBeat·13d ago
News Placeholder
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth...
Business Wire·13d ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners
Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...
MarketBeat·1mo ago
News Placeholder
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·1mo ago
News Placeholder
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·2mo ago
News Placeholder
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell
Wall Street Zen lowered shares of Sensus Healthcare from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·2mo ago
News Placeholder
Sensus Healthcare Q4 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and reimbursement milestone that management believes reshapes the company's...
MarketBeat·2mo ago
News Placeholder
Sensus Healthcare SRTS Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·2mo ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS
Sensus Healthcare (NASDAQ:SRTS - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.09) by...
MarketBeat·2mo ago
<
1
2
...
>

Latest SRTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.